Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

uniQure N.V. (QURE)

NASDAQ:QURE

US Market

QURE

uniQure

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

uniQure (QURE) Stock News & Sentiment

1,100 Followers

uniQure’s AMT-130 Gene Therapy Gains Momentum with FDA’s Accelerated Approval Pathway, Boosting Buy Rating

Ratings

uniQure’s AMT-130 Gene Therapy Gains Momentum with FDA’s Accelerated Approval Pathway, Boosting Buy Rating

14d ago

uniQure Reports 2024 Financial Results and Progress

Company Announcements

uniQure Reports 2024 Financial Results and Progress

21d ago

uniQure’s Promising Future: Buy Rating Backed by Advancements in Gene Therapy and Strong Financial Position

Ratings

uniQure’s Promising Future: Buy Rating Backed by Advancements in Gene Therapy and Strong Financial Position

23d ago

uniQure’s Promising Pipeline and Strategic Positioning Earns Buy Rating

Ratings

uniQure’s Promising Pipeline and Strategic Positioning Earns Buy Rating

2M ago

uniQure Secures FDA Agreement for AMT-130 Approval

Company Announcements

uniQure Secures FDA Agreement for AMT-130 Approval

4M ago

uniQure Begins Phase I/IIa Trial for AMT-260 Therapy

Company Announcements

uniQure Begins Phase I/IIa Trial for AMT-260 Therapy

4M ago

uniQure N.V. Reports Q3 2024 Progress and Financials

Company Announcements

uniQure N.V. Reports Q3 2024 Progress and Financials

5M ago

More QURE News >

QURE News on the Web

2025-03-01

uniQure Full Year 2024 Earnings: Misses Expectations

Yahoo Finance

Neutral

2025-02-27

Analysts Are Bullish on These Healthcare Stocks: Astria Therapeutics (ATXS), uniQure (QURE)

TipRanks News

Neutral

2025-02-27

UniQure Reports Q4 Loss, Misses Revenue Estimates

Yahoo Finance

Neutral

2025-02-27

UniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates

Zacks

Bearish

2025-02-27

uniQure Announces 2024 Financial Results and Highlights Recent Company Progress

Yahoo Finance

Neutral

2025-02-20

uniQure N.V. is a favorite amongst institutional investors who own 66%

Yahoo Finance

Neutral

2025-02-07

CSL Behring's Gene Therapy HEMGENIX® Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B

Yahoo Finance

Neutral

2025-02-03

uniQure Announces Completion of Enrollment in the First Cohort and Favorable Recommendation from the Independent Data Monitoring Committee for its Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

QURE

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is QURE’s Media Buzz Sentiment?

Currently, no data Available

What is QURE’s weekly average amount of articles?

Currently, no data Available

What is QURE’s News Sentiment?

59% of articles about QURE were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

PLXProtalix

DVAXDynavax

OGNOrganon

IMVTImmunovant

RBOTVicarious Surgical

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing